A military operation is the coordinated military actions of a state, or a non-state actor, in response to a developing situation. These actions are designed as a military plan to resolve the situation in the state or actors favor. Operations may be of a combat or non-combat nature and may be referred to by a code name for the purpose of national security. Military operations are often known for their more generally accepted common usage names than their actual operational objectives. Types of military operations
Military operations can be classified by the scale and scope of force employment, and their impact on the wider conflict. The scope of military operations can be:

Theater: this describes an operation over a large, often continental, area of operation and represents a strategic national commitment to the conflict, such as Operation Barbarossa, with general goals that encompass areas of consideration outside the military, such as the economic and political impact of military goals on areas concerned. Campaign: this describes either a subset of the theatre of operation, or a more limited geographic and operational strategic commitment, such as the Battle of Britain, and need not represent total national commitment to a conflict, or have broader goals outside the military impact.The United States just recently got out of some of the longest conflicts in the Military history.
Without treatment the infantile form (which can typically be predicted by mutation analysis) of the disease is particularly lethal - in these cases time to get on treatment is critical, with evidence that days (not weeks or months) matter.Myozyme (alglucosidase alfa) is a recombinant form of the human enzyme acid alpha-glucosidase, and is also currently being used to replace the missing enzyme. In a study which included the largest cohort of patients with Pompe disease treated with enzyme replacement therapy (ERT) to date findings showed that Myozyme treatment clearly prolongs ventilator-free survival and overall survival in patients with infantile-onset Pompe disease as compared to an untreated historical control population. Furthermore, the study demonstrated that initiation of ERT prior to 6 months of age, which could be facilitated by newborn screening, shows great promise to reduce the mortality and disability associated with this devastating disorder. Taiwan and several states in the United States have started the newborn screening and results of such regimen in early diagnosis and early initiation of the therapy have dramatically improved the outcome of the disease; many of these babies have reached the normal motor developmental milestones.Another factor affecting the treatment response is generation of antibodies against the infused enzyme, which is particularly severe in Pompe infants who have complete deficiency of the acid alpha-glucosidase. Immune tolerance therapy to eliminate these antibodies has improved the treatment outcome.A Late Onset Treatment Study (LOTS) was published in 2010.